TCAP and autosomal recessive limb-girdle muscular dystrophy type 2G: Our study suggests that idebenone might benefit LGMD2G zebrafish by reducing ROS and supports a new indication for idebenone as a potential LGMD2G therapeutic to be further investigated in a mouse model of LGMD2G.